> Details
Madurka, Ildiko;
Vishnevsky, Alexander;
Soriano, Joan B.;
Gans, Stephanus J.;
Ore, Danilo Joel Salazar;
Rendon, Adrian;
Ulrik, Charlotte S.;
Bhatnagar, Sushma;
Krishnamurthy, Srikanth;
Mc Harry, Kirsten;
Welte, Tobias;
Fernandez, Alberto A.;
Mehes, Beata;
Meiser, Karin;
Gatlik, Ewa;
Sommer, Ulrike;
Junge, Guido;
Rezende, Ederlon;
Fernandez, Alberto Alfredo;
Bagu, Ana Maria;
Amido, Florencia Heredia;
Costa, Maria Belen;
Brigante, Jorge Alejandro;
Franco, Gaston;
[...]
DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function
Sharing
Reference
management
Direct link
Bookmarks
Remove from
bookmarks
Share this by email
Share this on Twitter
Share this on Facebook
Share this on Whatsapp
- Media type: E-Article
- Title: DFV890: a new oral NLRP3 inhibitor—tested in an early phase 2a randomised clinical trial in patients with COVID-19 pneumonia and impaired respiratory function
- Contributor: Madurka, Ildiko; Vishnevsky, Alexander; Soriano, Joan B.; Gans, Stephanus J.; Ore, Danilo Joel Salazar; Rendon, Adrian; Ulrik, Charlotte S.; Bhatnagar, Sushma; Krishnamurthy, Srikanth; Mc Harry, Kirsten; Welte, Tobias; Fernandez, Alberto A.; Mehes, Beata; Meiser, Karin; Gatlik, Ewa; Sommer, Ulrike; Junge, Guido; Rezende, Ederlon; Fernandez, Alberto Alfredo; Bagu, Ana Maria; Amido, Florencia Heredia; Costa, Maria Belen; Brigante, Jorge Alejandro; Franco, Gaston; [...]
-
Published:
Springer Science and Business Media LLC, 2023
- Published in: Infection, 51 (2023) 3, Seite 641-654
- Language: English
- DOI: 10.1007/s15010-022-01904-w
- ISSN: 0300-8126; 1439-0973
- Origination:
- Footnote: